Neko Health Launches $500 AI Body Scan in New York
Neko Health launches its $500 body scan in New York after raising nearly $1 billion, with 300,000 waiting and US expansion facing key regulatory hurdles.
Summary
As of October 3, 2026, Swedish startup Neko Health, co-founded by Spotify’s David Ek and Hjalmar Nilsonne, had arrived in New York after raising nearly $1 billion. Its one-hour, $500 scan uses advanced computer vision and other technology to screen blood, skin and metabolism. Insurance does not cover it, although the fee should qualify for Health Savings Account spending. Neko says its global waitlist exceeds 300,000 as it considers broader US expansion.
Preface Ventures investor Farooq Abbasi, who has undergone two scans, says the blood test expanded from 15 biomarkers during his first visit to 55 on his latest. He argues that the AI-supported service provides actionable preventive-health insights rather than another wellness fad and could address low US preventive-care use linked to cost concerns. Neko still faces regulatory approval and scaling challenges, while Abbasi wants clinics nationwide and more venture funding for suitable healthcare companies.
Positives
- Nearly $1 billion in funding gives Neko Health substantial resources for its US expansion.
- More than 300,000 people have joined Neko Health’s global waitlist, indicating strong demand.
- The blood test expanded from 15 biomarkers to 55 between Farooq Abbasi’s two scans.
- The $500 fee should qualify for Health Savings Account spending despite lacking insurance coverage.
- Advanced computer vision screens for issues involving blood, skin and metabolism within one hour.
Risks & concerns
- The $500 scan is not covered by insurance, limiting affordability for some US patients.
- US expansion still requires regulatory approval and a workable approach to scaling clinics.
- Low preventive-care use in the US reflects cost concerns that Neko’s uninsured service may not overcome.
- Neko has not detailed a timetable or clinic count for expansion beyond New York.